Life Science Network Interview

Oslo,Thursday the 24th of October 2016

Arctic Pharma’s CEO, was interviewed by Life Science Network to discuss with them the challenges of running an early-stage biotech company and the importance of doing market research. The Life Science Network editorial team produces insightful news, interviews and research from the industry and many of the major conferences in life science and healthcare today.

The Hive

Oslo,Thursday the 20th of October 2016

Arctic Pharma is part of Elsevier’s ‘the Hive’. Elsevier is one of the world’s biggest providers of scientific, technical, and medical information. Being a company selected to be a part of the Hive is significant. It will give Arctic Pharma access to trustworthy data that will help us make better-informed decisions on drug development, and increase our productivity and scientific progress by reducing the time we spend searching data to find scientific and medical information that is most relevant to us. Arctic Pharma will also receive worldwide exposure by being one of the four-featured companies on their website and featured in their monthly blog.

Arctic Pharma featured in PR Newswire

Oslo,Thursday the 20th of October 2016

Arctic Pharma was announced as one of the 4 promising start-up biotech companies selected worldwide to participate in Elsevier’s ‘the Hive’.

Click on the picture to read more.

Arctic Pharma featured in Pharma R&D Today

Oslo,Thursday the 20th of October 2016

Arctic Pharma was featured together with Myelo Therapeutics as two start-ups developing promising cancer treatments.

Click on the picture to read more.

DNB NXT

Oslo,Thursday the 19th of October 2016

Arctic Pharma was one of the 40 in the semi-finals promoted through on stage presentation “pitching” our company during Oslo Innovation Week 2016 at DNB NXT 100 pitches event.

Click on the picture to read more.

Arctic Pharma attends largest pitch training in Oslo

Oslo,Thursday the 12th of September 2016

Arctic Pharma participated in pitch training in Oslo at DNB headquarters in Bjørvika.

Click on the picture to read more.

Arctic Pharma Joins Oslo Cancer Cluster

Oslo,10th of September 2016

Arctic Pharma became a member of the Oslo Cancer Cluster (OCC) an oncology research and industry cluster dedicated to accelerating the development of new cancer diagnostics and medicines. As a member we share the OCC vision “We are committed to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and medicines.”

Click on the picture to read more.

Arctic Pharma moves to OCCI

Oslo, 4th of July 2016

Arctic Pharma moved to new facilities at the Oslo Cancer Cluster Incubator (OCCI). 

Click on the picture to read more.